BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 30562867)

  • 21. Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages.
    Shimizu Y; Takamori A; Utsunomiya A; Kurimura M; Yamano Y; Hishizawa M; Hasegawa A; Kondo F; Kurihara K; Harashima N; Watanabe T; Okamura J; Masuda T; Kannagi M
    Cancer Sci; 2009 Mar; 100(3):481-9. PubMed ID: 19154412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.
    Yashiki S; Fujiyoshi T; Arima N; Osame M; Yoshinaga M; Nagata Y; Tara M; Nomura K; Utsunomiya A; Hanada S; Tajima K; Sonoda S
    AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1047-61. PubMed ID: 11485622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors.
    Kamigaki T; Kaneko T; Naitoh K; Takahara M; Kondo T; Ibe H; Matsuda E; Maekawa R; Goto S
    Anticancer Res; 2013 Jul; 33(7):2971-6. PubMed ID: 23780988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential immunogenicity of adult T cell leukemia cells in vivo.
    Kurihara K; Harashima N; Hanabuchi S; Masuda M; Utsunomiya A; Tanosaki R; Tomonaga M; Ohashi T; Hasegawa A; Masuda T; Okamura J; Tanaka Y; Kannagi M
    Int J Cancer; 2005 Mar; 114(2):257-67. PubMed ID: 15551352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult T-cell leukemia: future prophylaxis and immunotherapy.
    Kannagi M; Harashima N; Kurihara K; Utsunomiya A; Tanosaki R; Masuda M
    Expert Rev Anticancer Ther; 2004 Jun; 4(3):369-76. PubMed ID: 15161436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological risks of adult T-cell leukemia at primary HTLV-I infection.
    Kannagi M; Ohashi T; Harashima N; Hanabuchi S; Hasegawa A
    Trends Microbiol; 2004 Jul; 12(7):346-52. PubMed ID: 15223062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
    Ohshima K
    Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.
    Kobayashi H; Ngato T; Sato K; Aoki N; Kimura S; Tanaka Y; Aizawa H; Tateno M; Celis E
    Clin Cancer Res; 2006 Jun; 12(12):3814-22. PubMed ID: 16778109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice.
    Wang L; Xie Y; Ahmed KA; Ahmed S; Sami A; Chibbar R; Xu Q; Kane SE; Hao S; Mulligan SJ; Xiang J
    Breast Cancer Res Treat; 2013 Jul; 140(2):273-84. PubMed ID: 23881522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma.
    Arnulf B; Thorel M; Poirot Y; Tamouza R; Boulanger E; Jaccard A; Oksenhendler E; Hermine O; Pique C
    Leukemia; 2004 Jan; 18(1):126-32. PubMed ID: 14574331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.
    Ueda Y; Itoh T; Nukaya I; Kawashima I; Okugawa K; Yano Y; Yamamoto Y; Naitoh K; Shimizu K; Imura K; Fuji N; Fujiwara H; Ochiai T; Itoi H; Sonoyama T; Hagiwara A; Takesako K; Yamagishi H
    Int J Oncol; 2004 Apr; 24(4):909-17. PubMed ID: 15010829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer
    Chen J; Guo XZ; Li HY; Zhao JJ; Xu WD
    World J Gastroenterol; 2017 Feb; 23(5):817-829. PubMed ID: 28223726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human T-cell leukemia virus type I Tax induces the expression of dendritic cell markers associated with maturation and activation.
    Mostoller K; Norbury CC; Jain P; Wigdahl B
    J Neurovirol; 2004 Dec; 10(6):358-71. PubMed ID: 15765807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation and detection of HTLV-I Tax-specific CTLs by epitope expressing single-chain trimers of MHC class I in a rat model.
    Ohashi T; Nagai M; Okada H; Takayanagi R; Shida H
    Retrovirology; 2008 Oct; 5():90. PubMed ID: 18840303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular pathogenesis and its therapeutic implication for ATL].
    Ishitsuka K
    Rinsho Ketsueki; 2017; 58(10):2004-2011. PubMed ID: 28978842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination.
    Wei FQ; Sun W; Wong TS; Gao W; Wen YH; Wei JW; Wei Y; Wen WP
    J Exp Clin Cancer Res; 2016 Jan; 35():18. PubMed ID: 26795730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of two new HLA-A*1101-restricted tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantation.
    Harashima N; Tanosaki R; Shimizu Y; Kurihara K; Masuda T; Okamura J; Kannagi M
    J Virol; 2005 Aug; 79(15):10088-92. PubMed ID: 16014972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunotherapeutic efficacy of both helper T lymphocytes and cytotoxic T lymphocytes epitopes augmented dendritic cells tumor vaccine on gastric cancer].
    Li Q; Zhang Y; Chen XH; Cao WX; Gu QL; Zhu ZG; Liu BY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):148-51. PubMed ID: 16555158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
    Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
    J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.